Head-to-head · Cost-Efficiency Index
SnagRx vs AlyveRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
SnagRx
Shoppers who want a specifically-named compounding pharmacy but should confirm the promo price won't expire.
Visit SnagRxAlyveRx
Shoppers who specifically want a needle-free sublingual GLP-1 option alongside standard injections on the same platform.
Visit AlyveRxThe verdict
SnagRx takes it, leading the Cost-Efficiency Index 65 to 64. SnagRx is a telehealth platform offering compounded semaglutide and tirzepatide with unusually specific named pharmacy partners (RedRock, Health Warehouse, Precision Compounding, Triad Rx) and a claimed LegitScript certification. AlyveRx still earns a C — Shoppers who specifically want a needle-free sublingual GLP-1 option alongside standard injections on the same platform.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs SnagRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | SnagRx | AlyveRx |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 64/100 |
| Semaglutide / mo | $99/mo (flat at every dose, compounded) | $183/mo (starting dose, compounded) |
| Tirzepatide / mo | $149/mo (flat at every dose, compounded) | $283/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $828 | $2,196 |
| Tirzepatide / yr (modeled) | $1,428 | $3,396 |
| Coverage | All 50 states plus Washington D.C. (per Terms) | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #169 | #173 |
SnagRx
65/100Where the value is
- Names four specific, checkable compounding pharmacy partners
- Broad state coverage (48 states, only MS and LA excluded)
- Displays a LegitScript badge and claims certification
The tradeoffs
- Headline prices are shown against a struck-through 'regular price' -- classic promo-pricing signal, not confirmed as permanent
- Medical director exists but is not named
AlyveRx
64/100Where the value is
- Offers a genuinely needle-free sublingual delivery option (PermeAct) for both semaglutide and tirzepatide, not just injections
- Also carries brand-name Ozempic, Wegovy, and Mounjaro for patients who want an FDA-approved product
- All four price points (injection and drops, both drugs) are published upfront on the homepage before intake
The tradeoffs
- The dataset's previous $249/mo tirzepatide figure is the SUBLINGUAL DROPS price, not the standard injection ($283/mo) — confirm which form a quoted price refers to
- Sublingual PermeAct absorption relies on the company's own proprietary technology claims and is not FDA-reviewed for weight-loss efficacy
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.